Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Cardiologists play key role in helping patients mitigate high genetic CVD risk
• Mary Norine Walsh, MD, reflects on ACC presidency, changes in HF management
• FDA approves MR-conditional labeling for small pacemaker
• FDA: OTC aspirin labels with CV imagery should prompt consumers to consult physician
• Next-generation troponin T test receives FDA clearance
• Noninvasive 3D mapping system for arrhythmia location cleared by FDA
• 2 decades of MI
• Cybersecurity concerns prompt discussion on remote monitoring
• Iron: An emerging target for HF
• AHA: Prevalence of HF projected to rise dramatically; CVD still No. 1 killer in US, world
• CAC in younger adults linked to substantially increased CHD risk
• Consensus statement proposes standardized neurologic endpoints for CV trials
• DAPT, aspirin monotherapy confer similar outcomes in patients with diabetes after CABG
• Depression confers risk for CVD in similar magnitude to obesity, high cholesterol in men
• Dynamic resistance training may lower BP in patients with hypertension
• Functional status improves in most children who survive 1 year after heart transplant
• Genetic predisposition to abdominal adiposity increases type 2 diabetes, CHD risks
• Genomic blood test predicts revascularization events in PROMISE cohort
• Heart transplant listings increased in black patients with ACA Medicaid expansion
• High TMAO level predicts CV events in patients with ACS
• Higher cardiac radiation exposure may increase HF risk in women with breast cancer
• Higher SYNTAX score may predict benefit from CABG vs. medical therapy
• In patients undergoing noncardiac surgery, death and MI declining, but stroke increasing
• LV catheter ablation for certain arrhythmias may confer risk for brain lesions
• LVADs improve quality of life, increase lifetime costs in patients with advanced HF
• Meal planning, timing may affect CHD risk, related risk factors
• Mediterranean diet with virgin olive oil improves HDL function
• Moderate chocolate intake confers lower risk for HF vs. heavy or no intake in men
• Novel BP loci may offer new therapeutic targets for hypertension
• NSAIDs may increase myocardial infarction risk during acute respiratory infections
• Preterm delivery may increase CVD risk in women independent of other risk factors
• Proenkephalin A levels predictive of worsening renal status in patients with HF
• Regular exercise may reduce risk for hypertension in black adults
• Stroke risk higher with AF, insulin-requiring diabetes vs. without insulin
• Treatment to intensive systolic BP target could save 100,000 US lives annually
• Women with lower socioeconomic status at higher risk for CHD, CVD than men
• Worse outcomes related to elevated troponin levels in patients with decompensated HFpEF
• Coronary plaque burden elevated in relatives of patients with CAD
• National Wear Red Day increases awareness of women’s heart health in its 14th year
• Experts debate reimbursement, accreditation for carotid stenting
• New balloon-expandable stent graft yields positive outcomes in iliac artery
• Therapeutic hypothermia fails to benefit children surviving in-hospital cardiac arrest
• Vascular stent safe, effective in challenging long lesions
• The promise of a specific reversal agent for Factor Xa inhibitors Laura Mentzer, PharmD, BCPS, BCCCP; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• Trial Scorecard: CASABLANCA
• Trial Scorecard: ELSA – Brasil
• Trial Scorecard: GARFIELD-AF
• Trial Scorecard: GLORIA-AF
• Trial Scorecard: SMART
• Trial Scorecard: SORT OUT II
• Trial Scorecard: THAPCA-IH
• Trial Scorecard: TWENTE